Literature DB >> 21893101

Virostatic potential of micro-nano filopodia-like ZnO structures against herpes simplex virus-1.

Yogendra Kumar Mishra1, Rainer Adelung, Claudia Röhl, Deepak Shukla, Frank Spors, Vaibhav Tiwari.   

Abstract

Herpes simplex virus type-1 (HSV-1) entry into target cell is initiated by the ionic interactions between positively charged viral envelop glycoproteins and a negatively charged cell surface heparan sulfate (HS). This first step involves the induction of HS-rich filopodia-like structures on the cell surface that facilitate viral transport during cell entry. Targeting this initial first step in HSV-1 pathogenesis, we generated different zinc oxide (ZnO) micro-nano structures (MNSs) that were capped with multiple nanoscopic spikes mimicking cell induced filopodia. These MNSs were predicted to target the virus to compete for its binding to cellular HS through their partially negatively charged oxygen vacancies on their nanoscopic spikes, to affect viral entry and subsequent spread. Our results demonstrate that the partially negatively charged ZnO-MNSs efficiently trap the virions via a novel virostatic mechanism rendering them unable to enter into human corneal fibroblasts - a natural target cell for HSV-1 infection. The anti-HSV-1 activity of ZnO MNSs was drastically enhanced after creating additional oxygen vacancies under UV-light illumination. Our results provide a novel insight into the significance of ZnO MNSs as the potent HSV-1 inhibitor and rationalize their development as a novel topical agent for the prevention of HSV-1 infection.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21893101      PMCID: PMC4148000          DOI: 10.1016/j.antiviral.2011.08.017

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  40 in total

1.  A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry.

Authors:  D Shukla; J Liu; P Blaiklock; N W Shworak; X Bai; J D Esko; G H Cohen; R J Eisenberg; R D Rosenberg; P G Spear
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

2.  Neurovirulence and latency of drug-resistant clinical herpes simplex viruses in animal models.

Authors:  Sarah Dambrosi; Mélanie Martin; Kevin Yim; Brian Miles; Julio Canas; Yan Sergerie; Guy Boivin
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

3.  The Importance of Heparan Sulfate in Herpesvirus Infection.

Authors:  Christopher D O'Donnell; Deepak Shukla
Journal:  Virol Sin       Date:  2008-12-01       Impact factor: 4.327

4.  The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus.

Authors:  Kicki Nyberg; Maria Ekblad; Tomas Bergström; Craig Freeman; Christopher R Parish; Vito Ferro; Edward Trybala
Journal:  Antiviral Res       Date:  2004-07       Impact factor: 5.970

5.  Zinc Oxide Nanocrystals for Non-resonant Nonlinear Optical Microscopy in Biology and Medicine.

Authors:  Aliaksandr V Kachynski; Andrey N Kuzmin; Marcin Nyk; Indrajit Roy; Paras N Prasad
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2008-07-24       Impact factor: 4.126

Review 6.  Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis.

Authors:  Marco Rusnati; Chiara Urbinati
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

7.  The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender.

Authors:  James M Hill; Melvyn J Ball; Donna M Neumann; Ann M Azcuy; Partha S Bhattacharjee; Saadallah Bouhanik; Christian Clement; Walter J Lukiw; Timothy P Foster; Manish Kumar; Herbert E Kaufman; Hilary W Thompson
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

8.  A role for 3-O-sulfated heparan sulfate in cell fusion induced by herpes simplex virus type 1.

Authors:  Vaibhav Tiwari; Christian Clement; Michael B Duncan; Jinghua Chen; Jian Liu; Deepak Shukla
Journal:  J Gen Virol       Date:  2004-04       Impact factor: 3.891

9.  A novel function of heparan sulfate in the regulation of cell-cell fusion.

Authors:  Christopher D O'Donnell; Deepak Shukla
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

Review 10.  Nanobioimaging and sensing of infectious diseases.

Authors:  Padmavathy Tallury; Astha Malhotra; Logan M Byrne; Swadeshmukul Santra
Journal:  Adv Drug Deliv Rev       Date:  2009-11-25       Impact factor: 15.470

View more
  42 in total

1.  Prior inhibition of AKT phosphorylation by BX795 can define a safer strategy to prevent herpes simplex virus-1 infection of the eye.

Authors:  Tejabhiram Yadavalli; Rahul Suryawanshi; Marwan Ali; Aqsa Iqbal; Raghuram Koganti; Joshua Ames; Vinay Kumar Aakalu; Deepak Shukla
Journal:  Ocul Surf       Date:  2019-11-23       Impact factor: 5.033

Review 2.  Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.

Authors:  Jill M Steinbach
Journal:  Cell Mol Life Sci       Date:  2014-10-17       Impact factor: 9.261

3.  Antiviral Activity of Zinc Oxide Nanoparticles and Tetrapods Against the Hepatitis E and Hepatitis C Viruses.

Authors:  Jyoti Gupta; Minnah Irfan; Niranjan Ramgir; K P Muthe; A K Debnath; Shabnam Ansari; Jaya Gandhi; C T Ranjith-Kumar; Milan Surjit
Journal:  Front Microbiol       Date:  2022-06-23       Impact factor: 6.064

Review 4.  Role of metal and metal oxide nanoparticles as diagnostic and therapeutic tools for highly prevalent viral infections.

Authors:  Tejabhiram Yadavalli; Deepak Shukla
Journal:  Nanomedicine       Date:  2016-08-26       Impact factor: 5.307

Review 5.  Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeutics.

Authors:  Thessicar E Antoine; Paul J Park; Deepak Shukla
Journal:  Rev Med Virol       Date:  2013-02-26       Impact factor: 6.989

6.  Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection.

Authors:  Thessicar E Antoine; Yogendra K Mishra; James Trigilio; Vaibhav Tiwari; Rainer Adelung; Deepak Shukla
Journal:  Antiviral Res       Date:  2012-10-06       Impact factor: 5.970

7.  Cell entry mechanisms of HSV: what we have learned in recent years.

Authors:  Alex M Agelidis; Deepak Shukla
Journal:  Future Virol       Date:  2015-10-01       Impact factor: 1.831

8.  Antiviral Activity of Zinc Oxide Nanoparticles Mediated by Plumbago indica L. Extract Against Herpes Simplex Virus Type 1 (HSV-1).

Authors:  Mina Michael Melk; Seham S El-Hawary; Farouk Rasmy Melek; Dalia Osama Saleh; Omar M Ali; Mohamed A El Raey; Nabil Mohamed Selim
Journal:  Int J Nanomedicine       Date:  2021-12-18

Review 9.  Use of nanotechnology in combating coronavirus.

Authors:  Saee Gharpure; Balaprasad Ankamwar
Journal:  3 Biotech       Date:  2021-06-28       Impact factor: 2.406

10.  Tin oxide nanowires suppress herpes simplex virus-1 entry and cell-to-cell membrane fusion.

Authors:  James Trigilio; Thessicar E Antoine; Ingo Paulowicz; Yogendra K Mishra; Rainer Adelung; Deepak Shukla
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.